Adipose tissue biglycan as a potential anti-inflammatory target of sodium salicylate in mice fed a high fat diet

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Adapala, Venkata J ^a   Ward, Meliza ^a   Ajuwon, Kolapo M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; INTERLEUKIN 6; SALICYLATE SODIUM; SCLEROPROTEIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIGLYCAN GENE; BODY COMPOSITION; CD68 GENE; COL1A1 GENE; COL6A1 GENE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; INFLAMMATORY DISEASE; INTERLEUKIN 6 GENE; KNOCKOUT MOUSE; LIPID DIET; MALE; MARKER GENE; MESENTERY; MOUSE; NONHUMAN; REGULATOR GENE; TISSUE LEVEL; TOLL LIKE RECEPTOR 4 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; WILD TYPE;

MUS;

EID: 84862162972     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-15     Document Type: Article

References (29)

1. Diabetes and atherothrombotic disease: linked through inflammation? Tracy RP, Semin Vasc Med 2002 2 67 73 10.1055/s-2002-23097 16222597
2. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR, Obes Surg 2004 14 589 600 10.1381/096089204323093345 15186624 (Pubitemid 38716577)
3. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Trayhurn P, Wood IS, Br J Nutr 2004 92 347 355 10.1079/BJN20041213 15469638 (Pubitemid 40277057)
4. Lumican is required for neutrophil extravasation following corneal injury and wound healing. Hayashi Y, Call MK, Chikama T, Liu H, Carlson EC, Sun Y, Pearlman E, Funderburgh JL, Babcock G, Liu CY, Ohashi Y, Kao WW, J Cell Sci 2010 123 2987 95 10.1242/jcs.068221 20699360
5. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Gröne HJ, Schaefer L, J Biol Chem 2009 284 24035 24048 10.1074/jbc.M109.014266 19605353
6. Metabolic dysregulation and adipose tissue fibrosis: Role of collagen VI. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE, Mol Cell Biol 2009 29 1575 1591 10.1128/MCB.01300-08 19114551
7. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-Millo M, Poitou C, Basdevant A, Stich V, Viguerie N, Langin D, Bedossa P, Zucker JD, Clement K, Genome Biol 2008 21 9 R14
8. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, J Clin Invest 2005 115 2223 2233 10.1172/JCI23755 16025156 (Pubitemid 41134165)
9. Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin. Ward M, Ajuwon KM, Cell Prolif 2011 44 343 351 10.1111/j.1365-2184.2011.00763.x 21702857
10. Inhibition of prostaglandin synthesis as a mechanism of action of the aspirin-like drugs. Vane JR, Nature New Biol 1971 231 232 235 5284360
11. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Schwenger PD, Alpert E, Skolnik Y, Vilcek J, Mol Cell Biol 1998 18 78 84 9418855 (Pubitemid 28021019)
12. Inhibition of NF-kappa B by sodium salicylate and aspirin. Kopp E, Ghosh S, Science 1994 265 956 959 10.1126/science.8052854 8052854
13. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Grilli M, Pizzi M, Memo M, Spano P, Science 1996 274 1383 1385 10.1126/science.274.5291.1383 8910280 (Pubitemid 26391464)
14. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase-β Yin M, Yamamoto J, Gaynor RB, Nature 1998 396 77 80 10.1038/23948 9817203 (Pubitemid 28520452)
15. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE, Science 2001 293 1673 1677 10.1126/science.1061620 11533494 (Pubitemid 32807849)
16. Insulin resistance and chronic cardiovascular inflammatory syndrome. Fernandez-Real JM, Ricart W, Endocr Rev 2003 24 278 301 10.1210/er.2002-0010 12788800 (Pubitemid 36724371)
17. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, Forbes J, de Courten B, Krakoff J, Diabetologia 2009 52 385 393 10.1007/s00125-008-1239-x 19104769
18. Salicylate, a Powerful Inhibitor of Free Fatty Acid Release. Bizzi A, Codengoni M, Garattini S, Nature 1964 204 1205 14268588
19. Salicylate Inhibits Macrophage-Secreted Factors Induced Adipocyte Inflammation and Changes of Adipokines in 3T3-L1 Adipocytes. An Y, Liu K, Zhou Y, Liu B, Inflammation 2009 32 296 303 10.1007/s10753-009-9135-1 19609658
20. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I, J Clin Endocrinol Metab 2008 93 578 583 10.1210/jc.2007-2185 18029454 (Pubitemid 351240834)
21. TLR4 links innate immunity and fatty acid-induced insulin resistance. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS, J Clin Invest 2006 116 3015 3025 10.1172/JCI28898 17053832 (Pubitemid 44684486)
22. Adipose tissue is a regulated source of interleukin-10. Juge-Aubry CE, Somm E, Pernin A, Alizadeh N, Giusti V, Dayer JM, Meier CA, Cytokine 2005 29 270 274 15749027 (Pubitemid 40320927)
23. Adipose tissue collagen VI in obesity. Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, Ravussin E, Bray GA, Smith SR, J Clin Endocrinol Metab 2009 94 5155 5162 10.1210/jc.2009-0947 19837927
24. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D, Mol Endocrinol 2009 23 11 24 18945811
25. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1β and tumor necrosis factor-α Tufvesson E, Westergren-Thorsson G, J Cell Biochem 2000 77 298 309 10.1002/(SICI)1097- 4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D 10723095 (Pubitemid 30176658)
26. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grässel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H, Am J Pathol 2002 160 1181 1191 10.1016/S0002-9440(10)64937-1 11891213 (Pubitemid 34224603)
27. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Samaras K, Botelho NK, Chisholm DJ, Lord RV, Obesity 2010 18 884 889 10.1038/oby.2009.443 20019678
28. The human visceral fat depot has a unique inflammatory profile. Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T, Obesity 2010 18 879 883 10.1038/oby.2010.22 20186138
29. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Alberti L, Gilardini L, Zulian A, Micheletto G, Peri G, Doni A, Mantovani A, Invitti C, Atherosclerosis 2009 202 455 460 10.1016/j.atherosclerosis.2008.05.015 18571180